Bicycle raises £20m series A from prime investor syndicate
Bicycle Therapeutics of the UK has raised £20m in a series A financing round for the clinical development of its therapeutic bicycle drug candidates in oncology.
Bicycle Therapeutics of the UK has raised £20m in a series A financing round for the clinical development of its therapeutic bicycle drug candidates in oncology.